Shanghai Kindly Enterprise Development GroupLTD (SHSE:603987) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥2.45b (down 21% from FY 2022).
- Net income: CN¥230.9m (down 26% from FY 2022).
- Profit margin: 9.4% (in line with FY 2022).
- EPS: CN¥0.53 (down from CN¥0.71 in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Shanghai Kindly Enterprise Development GroupLTD Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) also missed analyst estimates by 22%.
Looking ahead, revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Medical Equipment industry in China.
Performance of the Chinese Medical Equipment industry.
The company’s shares are down 5.4% from a week ago.
Risk Analysis
We don’t want to rain on the parade too much, but we did also find 1 warning sign for Shanghai Kindly Enterprise Development GroupLTD that you need to be mindful of.
Valuation is complex, but we’re helping make it simple.
Find out whether Shanghai Kindly Enterprise Development GroupLTD is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
